Silverlode was engaged by a CU Innovations (CUI), which is focused on biomedical technology commercialization, to estimate the impacts of the organization’s activities. Part of the medical campus of a leading public research university, CUI brings together industry partners, entrepreneurs, and investors. Silverlode analyzed the impact of CUI's commercial relationships including equity investments in early-stage businesses, licensing, and other revenue generating activities. The study will be used to continue to support commercialization and funding activities.